StockNews.com Initiates Coverage on Reata Pharmaceuticals (N

StockNews.com initiated coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research report report published on Saturday. The brokerage issued a sell rating on the stock. Several other research analysts have also commented on RETA. LADENBURG THALM/SH SH lowered shares of Reata Pharmaceuticals from a buy rating to a neutral rating and […]

Related Keywords

China , Robertw Baird , Andrea Loewen , Leerink Partnrs , China Universal Asset Management Co , Securities Exchange Commission , Reata Pharmaceuticals Company Profile , Institutional Investors Weigh In On Reata Pharmaceuticals , Visionpoint Advisory Group , Reata Pharmaceuticals Price Performance , Jefferies Financial Group , Belpointe Asset Management , Reata Pharmaceuticals Inc , Analyst Recommendations For Reata Pharmaceuticals , Reata Pharmaceuticals , News Ratings For Reata Pharmaceuticals Daily , International Assets Investment Management , Free Report , Financial Group , Get Free Report , Director Shamim Ruff , Exchange Commission , Asset Management , Assets Investment Management , Universal Asset Management , Point Advisory Group , Strs Ohio , Reata Pharmaceuticals Daily , Nasdaq Reta , Greta , Medical , Initiated Coverage , Stocknews Com ,